Shares of Enzo Biochem Inc. (ENZ) continue to spike in pre-market today, after the company announced that its wholly owned subsidiary, Enzo Clinical Labs Inc., would begin accepting specimens for novel Coronavirus (COVID-19) testing next week.
from RTT - Before the Bell https://ift.tt/2IlX5OK
via IFTTT
No comments:
Post a Comment